Company Results (links open in a new window)
|
Date (document was filed at Companies House)
|
Type
|
Description (of the document filed at Companies House)
|
View / Download (PDF file, link opens in new window)
|
|
21 Feb 2024 |
CS01 |
Confirmation statement made on 7 February 2024 with no updates
|
|
|
03 Oct 2023 |
AA |
Accounts for a small company made up to 31 December 2022
|
|
|
22 Aug 2023 |
TM01 |
Termination of appointment of David Min Chao as a director on 17 August 2023
|
|
|
28 Jul 2023 |
SH19 |
Statement of capital on 28 July 2023
|
|
|
28 Jul 2023 |
SH20 |
Statement by Directors
|
|
|
28 Jul 2023 |
CAP-SS |
Solvency Statement dated 28/07/23
|
|
|
28 Jul 2023 |
RESOLUTIONS |
Resolutions
-
RES06 ‐
Resolution of reduction in issued share capital
-
RES13 ‐
Canellation of share premium account/amount credited to the reserves 28/07/2023
|
|
|
01 Mar 2023 |
CS01 |
Confirmation statement made on 7 February 2023 with updates
|
|
|
27 Jan 2023 |
MA |
Memorandum and Articles of Association
|
|
|
05 Jan 2023 |
PSC02 |
Notification of Centessa Pharmaceuticals (Uk) Limited as a person with significant control on 20 December 2022
|
|
|
05 Jan 2023 |
PSC07 |
Cessation of Centessa Pharmaceuticals Plc as a person with significant control on 20 December 2022
|
|
|
09 Nov 2022 |
AP01 |
Appointment of Richard Menziuso as a director on 1 November 2022
|
|
|
03 Nov 2022 |
CS01 |
Confirmation statement made on 21 October 2022 with updates
|
|
|
06 Oct 2022 |
AA |
Accounts for a small company made up to 31 December 2021
|
|
|
01 Aug 2022 |
TM01 |
Termination of appointment of Marella Thorell as a director on 31 July 2022
|
|
|
15 Mar 2022 |
SH01 |
Statement of capital following an allotment of shares on 14 March 2022
|
|
|
10 Jan 2022 |
PSC05 |
Change of details for Centessa Pharmaceuticals Limited as a person with significant control on 14 May 2021
|
|
|
07 Jan 2022 |
PSC05 |
Change of details for Centessa Pharmaceuticals Limited as a person with significant control on 4 May 2021
|
|
|
07 Jan 2022 |
PSC05 |
Change of details for United Medicines Biopharma Limited as a person with significant control on 17 February 2021
|
|
|
05 Jan 2022 |
PSC05 |
Change of details for United Medicines Biopharma Limited as a person with significant control on 29 January 2021
|
|
|
01 Dec 2021 |
AP01 |
Appointment of David Min Chao as a director on 30 November 2021
|
|
|
30 Nov 2021 |
TM01 |
Termination of appointment of Saurabh Saha as a director on 30 November 2021
|
|
|
30 Nov 2021 |
AP04 |
Appointment of Oakwood Corporate Secretary Limited as a secretary on 30 November 2021
|
|
|
30 Nov 2021 |
AD01 |
Registered office address changed from C/O the Cambridge Partnership Limited the Dorothy Hodgkin Building Babraham Research Campus, Babraham Cambridge CB22 3AT United Kingdom to 3rd Floor 1 Ashley Road Altrincham Cheshire WA14 2DT on 30 November 2021
|
|
|
05 Nov 2021 |
TM02 |
Termination of appointment of the Cambridge Partnership Limited as a secretary on 1 November 2021
|
|